Integral Diagnostics Limited
ITGDF
$0.98
-$1.05-51.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 52.79% | 41.44% | 31.29% | 19.18% | 6.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.79% | 41.44% | 31.29% | 19.18% | 6.90% |
| Cost of Revenue | 53.14% | 42.69% | 33.43% | 20.65% | 7.72% |
| Gross Profit | 52.03% | 38.78% | 26.82% | 16.10% | 5.17% |
| SG&A Expenses | 49.72% | 37.71% | 27.02% | 16.66% | 6.10% |
| Depreciation & Amortization | 43.86% | 30.60% | 18.67% | 11.93% | 4.98% |
| Other Operating Expenses | 46.47% | 35.56% | 26.37% | 29.21% | 33.47% |
| Total Operating Expenses | 52.07% | 40.91% | 30.95% | 19.06% | 7.01% |
| Operating Income | 60.29% | 46.90% | 34.75% | 20.42% | 5.76% |
| Income Before Tax | 174.34% | 175.77% | 119.85% | 118.39% | 117.08% |
| Income Tax Expenses | 221.08% | 151.03% | 86.01% | 26.64% | -22.15% |
| Earnings from Continuing Operations | 146.60% | 134.16% | 107.68% | 108.72% | 109.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 143.82% | 133.61% | 107.45% | 108.60% | 109.91% |
| EBIT | 60.29% | 46.90% | 34.75% | 20.42% | 5.76% |
| EBITDA | 54.47% | 40.41% | 27.74% | 11.97% | -2.96% |
| EPS Basic | 53.13% | 120.96% | 104.53% | 107.12% | 109.93% |
| Normalized Basic EPS | 180.23% | 37.45% | -33.52% | -15.92% | 34.09% |
| EPS Diluted | 51.88% | 120.83% | 104.53% | 107.11% | 109.89% |
| Normalized Diluted EPS | 176.27% | 35.21% | -35.20% | -16.80% | 35.11% |
| Average Basic Shares Outstanding | 53.24% | 42.44% | 31.32% | 17.29% | 3.23% |
| Average Diluted Shares Outstanding | 55.38% | 44.29% | 32.86% | 17.67% | 2.55% |
| Dividend Per Share | 22.45% | 15.40% | 9.71% | 2.57% | -4.25% |
| Payout Ratio | -0.28% | 5.47% | 17.94% | 13.36% | 9.96% |